Skip to main content

Advertisement

Log in

Correlations Between Prognosis and Regional Biomarker Profiles in Head and Neck Squamous Cell Carcinomas

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Head and neck squamous cell carcinomas (HNSCC) show diverse clinicopathological features and are mostly linked with poor outcome. In this study, we tested if the expression of tumor growth, cell cycle and basement membrane anchorage related biomarkers allow prognostic and clinicopathological stratification of HNSCC. Archived HNSCC samples from 226 patients included into tissue microarrays (TMA) were tested using immunohistochemistry. Histopathological evaluation and the analysis of immunostaining for EGFR, Ki67, p53, p16ink4 and Collagen XVII proteins were carried out in digital whole slides. Statistical evaluation was carried out using Pearson’s Chi-square test and Kaplan-Meier survival analysis. In the tested cohort, hypopharyngeal cancers had the least favorable, and glottic cancers had the most favorable prognosis. High Ki67 positive tumor cell fractions were associated with significantly worse prognosis and elevated rate of lymph node metastasis. Both Ki67 and EGFR expression correlated significantly with the tumor localization. Ki67 index was the highest in the hypopharyngeal region and it proved to be the lowest in the glottic region. EGFR expression was the highest in the oral cavity and the lowest in the glottic region. The survival rate of patients with p16ink4-negative cancer was significantly lower than of those with p16ink4-positive disease. A significant inverse correlation was found between histological grade and the prognosis of HNSCC. Our data support that elevated Ki67 positive proliferating cell fractions contribute to the unfavorable prognosis of hypopharyngeal cancers, while glottic cancers have the most favorable prognosis because of the lowest Ki67 expression rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108

    Article  PubMed  Google Scholar 

  2. Jay F. Piccirillo IC, Marsha E. Reichman (2007) Chapter 2: Cancers of the Head and Neck. In: Ries LAG YJ, Keel GE, Eisner MP, Lin YD, Horner M-J (ed) SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program. NIH Pub No. 07–6215, Bethesda, MD

  3. Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer H-R, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359(11):1116–1127

    Article  CAS  PubMed  Google Scholar 

  4. Barzan L, Veronesi A, Caruso G, Serraino D, Magri D, Zagonel V, Tirelli U, Comoretto R, Monfardini S (1990) Head and neck cancer and ageing: a retrospective study in 438 patients. J Laryngol Otol 104(8):634–640

    Article  CAS  PubMed  Google Scholar 

  5. Massano J, Regateiro FS, Januario G, Ferreira A (2006) Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102(1):67–76

    Article  PubMed  Google Scholar 

  6. Ang KK, Sturgis EM (2012) Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 22(2):128–142. doi:10.1016/j.semradonc.2011.12.004

    Article  PubMed  Google Scholar 

  7. Franceschi S, Munoz N, Bosch XF, Snijders PJ, Walboomers JM (1996) Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 5(7):567–575

    CAS  PubMed  Google Scholar 

  8. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35. doi:10.1056/NEJMoa0912217

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Smeets SJ, Hesselink AT, Speel E-JM, Haesevoets A, Snijders PJF, Pawlita M, Meijer CJLM, Braakhuis BJM, Leemans CR, Brakenhoff RH (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121(11):2465–2472. doi:10.1002/ijc.22980

    Article  CAS  PubMed  Google Scholar 

  10. Licitra L, Storkel S, Kerr KM, Van Cutsem E, Pirker R, Hirsch FR, Vermorken JB, Von Heydebreck A, Esser R, Celik I, Ciardiello F (2013) Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies. Eur J Cancer 49(6):1161–1168

    Article  CAS  PubMed  Google Scholar 

  11. Tamas L, Szentkuti G, Eros M, Danos K, Brauswetter D, Szende B, Zsakovics I, Krenacs T (2011) Differential biomarker expression in head and neck cancer correlates with anatomical localization. Pathol Oncol Res 17(3):721–727

    Article  CAS  PubMed  Google Scholar 

  12. Krenacs T, Kiszner G, Stelkovics E, Balla P, Teleki I, Nemeth I, Varga E, Korom I, Barbai T, Plotar V, Timar J, Raso E (2012) Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis. Histochem Cell Biol 138(4):653–667. doi:10.1007/s00418-012-0981-9

    Article  CAS  PubMed  Google Scholar 

  13. Repassy G, Czigner J, Ribari O, Lapis K (1988) The barrier-like role of activated connective tissue against the spread of supraglottic laryngeal carcinoma. Arch Oto-Rhino-Laryngol 245(3):151–154

    Article  CAS  Google Scholar 

  14. van der Schroeff MP, Baatenburg de Jong RJ (2009) Staging and prognosis in head and neck cancer. Oral Oncol 45 (4–5):356–360. doi: http://dx.doi.org/10.1016/j.oraloncology.2008.05.022

  15. Takes RP (2004) Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers. Oral Oncol 40(7):656–667

    Article  PubMed  Google Scholar 

  16. O-charoenrat P, Pillai G, Patel S, Fisher C, Archer D, Eccles S, Rhys-Evans P (2003) Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol 39(4):386–390

    Article  CAS  PubMed  Google Scholar 

  17. Nilsson K, Svensson S, Landberg G (2004) Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior. Mod Pathol 17(12):1464–1474

    Article  CAS  PubMed  Google Scholar 

  18. Ai LB, Stephenson KK, Ling WH, Zuo CL, Mukunyadzi P, Suen JY, Hanna E, Fan CY (2003) The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: A promoter methylation and protein expression study in 100 cases. Mod Pathol 16(9):944–950. doi:10.1097/01.mp.0000085760.74313.dd

    Article  PubMed  Google Scholar 

  19. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Sasaki C, Rimm DL, Psyrri A (2004) Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res 10(17):5684–5691. doi:10.1158/1078-0432.ccr-04-0448

    Article  CAS  PubMed  Google Scholar 

  20. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168(4):357–363

    Article  CAS  PubMed  Google Scholar 

  21. Matsumoto M, Komiyama K, Okaue M, Shimoyama Y, Iwakami K, Namaki S, Tanaka H, Moro I, Sato H (1999) Predicting tumor metastasis in patients with oral cancer by means of the proliferation marker Ki67. J Oral Sci 41(2):53–56

    Article  CAS  PubMed  Google Scholar 

  22. Sittel C, Eckel HE, Damm M, von Pritzbuer E, Kvasnicka HM (2000) Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 110(6):1012–1017. doi:10.1097/00005537-200006000-00024

    Article  CAS  PubMed  Google Scholar 

  23. Roland NJ, Caslin AW, Bowie GL, Jones AS (1994) Has the cellular proliferation marker ki67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol Allied Sci 19(1):13–18. doi:10.1111/j.1365-2273.1994.tb01140.x

    Article  CAS  PubMed  Google Scholar 

  24. Berrino F, Gatta G (1998) Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group. Eur J Cancer 34(14 Spec No):2154–2161

    Article  CAS  PubMed  Google Scholar 

  25. Franzke C-W, Bruckner P, Bruckner-Tuderman L (2005) Collagenous transmembrane proteins: recent insights into biology and pathology. J Biol Chem 280(6):4005–4008

    Article  CAS  PubMed  Google Scholar 

  26. Stelkovics E, Korom I, Marczinovits I, Molnar J, Rasky K, Raso E, Ficsor L, Molnar B, Kopper L, Krenacs T (2008) Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy. Appl Immunohistochem Mol Morphol 16(5):433–441

    Article  CAS  PubMed  Google Scholar 

  27. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G (1992) Frequent p53 mutations in head and neck cancer. Cancer Res 52(21):5997–6000

    CAS  PubMed  Google Scholar 

  28. Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM (2010) A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev 19(2):574–587

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Bradford CR, Zhu S, Ogawa H, Ogawa T, Ubell M, Narayan A, Johnson G, Wolf GT, Fisher SG, Carey TE (2003) p53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck 25(8):654–661

    Article  PubMed  Google Scholar 

  30. Perisanidis C, Perisanidis B, Wrba F, Brandstetter A, El Gazzar S, Papadogeorgakis N, Seemann R, Ewers R, Kyzas PA, Filipits M (2012) Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. J Oral Pathol Med 41(1):40–46

    Article  PubMed  Google Scholar 

  31. Tamas L, Kraxner H, Mechtler L, Repassy G, Ribari O, Hirschberg A, Szentkuti G, Jaray B, Szentirmay Z (2000) Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies. Anticancer Res 20(5 C):4031–4038

    CAS  PubMed  Google Scholar 

  32. Grandis JR, Tweardy DJ (1993) Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53(15):3579–3584

    CAS  PubMed  Google Scholar 

  33. Grandis JR, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ (1998) Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90(11):824–832

    Article  Google Scholar 

  34. Szabo B, Nelhubel GA, Karpati A, Kenessey I, Jori B, Szekely C, Petak I, Lotz G, Hegedus Z, Hegedus B, Fule T, Dome B, Timar J, Tovari J (2011) Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncol 47(6):487–496

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of Interest

Conflict of interest statement: We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriella Szentkúti.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Szentkúti, G., Dános, K., Brauswetter, D. et al. Correlations Between Prognosis and Regional Biomarker Profiles in Head and Neck Squamous Cell Carcinomas. Pathol. Oncol. Res. 21, 643–650 (2015). https://doi.org/10.1007/s12253-014-9869-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-014-9869-4

Keywords

Navigation